Slide 1 1 Statistical and Practical Aspects of a Non-Stop Drug Development Strategy Karen L. Kesler and Ronald W. Helms Rho, Inc. Contact: [email protected] Slide 2 2…

Slide 1 1 Pharmacovigilance Lindsey Connery Pharmacovigilance Manager, Cancer Research UK Clinical Trials Unit, Glasgow Slide 2 2 Pharmacovigilance What is Pharmacovigilance?…

Slide 1 Electronic Diaries: Impact on Drug Development Saul Shiffman, Ph.D. Chief Science Officer invivodata, inc. Advisory Committee for Pharmaceutical Science 19-20 October,…

Slide 1 ICTW, Cordoba, Argentina Clinical Research Design & Methodology: Phase III Trials Ian Tannock, MD, PhD, DSc Princess Margaret Cancer Centre & University of…

Slide 1 PET/CT Imaging and Cancer Response to Treatment Dr. François Bénard Slide 2 Potential Conflict of Interest None Slide 3 PET/CT imaging and cancer response to treatment…

Slide 1 A Report to the National Cancer Advisory Board from the Translational Research Working Group June 15, 2007 - Bethesda, Maryland Ernest Hawk, MD, MPH NCI/OD/Office…

Slide 1 Pilot Studies Nuts and Bolts Deborah Grady, MD, MPH Professor of Medicine Associate Dean for Clinical and Translational Research UCSF Slide 2 Pilot Studies Small…

Implementation Research: Lessons Learned in OKPRN James W. Mold, M.D., M.P.H. Department of Family and Preventive Medicine University of Oklahoma Health Sciences Center Oklahoma…

Wavelet transformation Emrah Duzel Institute of Cognitive Neuroscience UCL Why analyse neural oscillations? Temporal code of information processing (versus rate code) Functional…

How many pathogen inactivation systems for platelets and plasma are proven? INTERCEPT Pathogen Inactivation Front Cover ONE pathogen inactivation system for platelets and…